Schrödinger, Inc.

NasdaqGS:SDGR Voorraadrapport

Marktkapitalisatie: US$1.4b

Schrödinger Beheer

Beheer criteriumcontroles 4/4

De CEO Schrödinger is Ramy Farid, benoemd in Jan2008, heeft een ambtstermijn van 16.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 3.12M, bestaande uit 21.7% salaris en 78.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.25% van de aandelen van het bedrijf, ter waarde $ 3.46M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.1 jaar en 5.6 jaar.

Belangrijke informatie

Ramy Farid

Algemeen directeur

US$3.1m

Totale compensatie

Percentage CEO-salaris21.7%
Dienstverband CEO16.8yrs
Eigendom CEO0.3%
Management gemiddelde ambtstermijn7.1yrs
Gemiddelde ambtstermijn bestuur5.6yrs

Recente managementupdates

We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Jun 12
We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Recent updates

Schrödinger's Path Forward: AI, Cash Burn, And Clinical Uncertainty

Oct 17

Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues

Sep 27
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues

Schrodinger: More Drug Discovery Validation

Aug 06

Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation

Aug 05
Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation

We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Jun 12
We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Schrödinger: More Pharmaceutical Than Software

May 07

Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar

May 02
Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar

Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially

Mar 01
Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially

Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024

Mar 01

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Feb 28
Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%

Feb 01
The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%

Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable

Dec 18
Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Sep 28
Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?

Jul 01
Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?

Schrödinger: Q2 Earnings Supports Growth Narrative

Aug 26

Schrödinger appoints Dr. Geoffrey Porges as finance chief

Aug 18

Sizing Up Schrodinger

Jun 06

Schrödinger: Holding The Keys To Discovery

Mar 26

Schrodinger: A Long-Term Hold For Biotech Investors With Upside Potential Too

Mar 15

Schrödinger: Conviction Remains High, Q4 Report And Guidance Will Be Critical

Jan 06

After Its Stock Price Doubled Last Year, Why Schrödinger Is Slumping Now

Nov 24

We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow

Nov 12
We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow

Analyse CEO-vergoeding

Hoe is Ramy Farid's beloning veranderd ten opzichte van Schrödinger's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$201m

Mar 31 2024n/an/a

-US$143m

Dec 31 2023US$3mUS$677k

US$41m

Sep 30 2023n/an/a

US$44m

Jun 30 2023n/an/a

US$66m

Mar 31 2023n/an/a

US$14m

Dec 31 2022US$4mUS$651k

-US$149m

Sep 30 2022n/an/a

-US$153m

Jun 30 2022n/an/a

-US$148m

Mar 31 2022n/an/a

-US$135m

Dec 31 2021US$8mUS$620k

-US$100m

Sep 30 2021n/an/a

-US$81m

Jun 30 2021n/an/a

-US$42m

Mar 31 2021n/an/a

-US$11m

Dec 31 2020US$9mUS$526k

-US$24m

Sep 30 2020n/an/a

-US$20m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$33m

Dec 31 2019US$633kUS$478k

-US$25m

Sep 30 2019n/an/a

-US$24m

Jun 30 2019n/an/a

-US$24m

Mar 31 2019n/an/a

-US$29m

Dec 31 2018US$1mUS$464k

-US$28m

Compensatie versus markt: De totale vergoeding ($USD 3.12M ) Ramy } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.36M ).

Compensatie versus inkomsten: De vergoeding van Ramy is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Ramy Farid (59 yo)

16.8yrs

Tenure

US$3,124,165

Compensatie

Dr. Ramy Farid, Ph.D. is Independent Director of Vir Biotechnology, Inc. from May 29, 2024. He serves as the President of Schrödinger, Inc. since January 2008 and has been its Chief Executive Officer since...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Ramy Farid
CEO, President & Director16.8yrsUS$3.12m0.25%
$ 3.5m
Richard Friesner
Co-Founder34.3yrsUS$1.09m1.7%
$ 23.2m
Geoffrey Porges
Executive VP & CFO2.3yrsUS$1.65m0.0078%
$ 106.8k
Robert Abel
Executive VPless than a yearUS$1.70m0.0020%
$ 26.9k
Karen Akinsanya
President of Research & Development Therapeutics6.6yrsUS$1.68m0%
$ 0
Margaret Han Dugan
Chief Medical Officer1.3yrsUS$3.46m0.0031%
$ 41.7k
William Goddard
Co-Founder & Scientific Advisorno datageen gegevensgeen gegevens
Kenneth Lorton
Executive VP7.6yrsUS$4.49m0.049%
$ 674.8k
Shane Brauner
Executive VP & Chief Information Officer7.8yrsgeen gegevensgeen gegevens
Jaren Madden
Senior Vice President of Investor Relations & Corporate Affairs4.8yrsgeen gegevensgeen gegevens
Yvonne Tran
Corporate Secretary14.8yrsUS$1.47m0.0086%
$ 117.7k
Mathew Halls
Senior Vice President of Materials Scienceno datageen gegevensgeen gegevens

7.1yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SDGR is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.1 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Ramy Farid
CEO, President & Director11.9yrsUS$3.12m0.25%
$ 3.5m
Richard Friesner
Co-Founder34.3yrsUS$1.09m1.7%
$ 23.2m
William Goddard
Co-Founder & Scientific Advisorno datageen gegevensgeen gegevens
Michael Lynton
Independent Chairman of the Board6.8yrsUS$727.05k0.0086%
$ 117.4k
Gary Ginsberg
Independent Director4.6yrsUS$689.55k0.0086%
$ 117.4k
Gary Sender
Independent Director5.3yrsUS$707.05k0.0086%
$ 117.4k
Vijay Pande
Scientific Advisorno datageen gegevensgeen gegevens
William Jorgensen
Scientific Advisorno datageen gegevensgeen gegevens
Rosana Kapeller-Libermann
Independent Director5.8yrsUS$687.05k0.0086%
$ 117.4k
Brian Shoichet
Scientific Advisorno datageen gegevensgeen gegevens
Nancy Thornberry
Independent Director5.2yrsUS$684.55k0.0086%
$ 117.4k
Jeffrey Chodakewitz
Independent Director4.6yrsUS$692.05k0.0086%
$ 117.4k

5.6yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SDGR wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.6 jaar).